X

Xencor
D

XNCR

15.740
USD
-0.03
(-0.19%)
مغلق
حجم التداول
13,731
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
1,101,517,152
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    5.10
    (1.71%)
    303.15 USD
    BIIB
    BIIB
    3.560
    (2.60%)
    140.630 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    B
    BMRN
    -0.525
    (-0.76%)
    68.215 USD
    C
    CLDT
    -0.18500
    (-2.23%)
    8.11000 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    ILMN
    ILMN
    -3.080
    (-3.17%)
    94.180 USD
    I
    INCY
    0.790
    (1.11%)
    72.150 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    T
    TGTX
    -0.040
    (-0.13%)
    30.900 USD
    المزيد
الأخبار
المقالات

العنوان: Xencor

القطاع: Healthcare
الصناعة: Biotechnology
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.